5 hours Zacks Research Equities Analysts Reduce Earnings Estimates for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) MarketBeat
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Investment analysts at Zacks Research cut their Q1 2025 earnings estimates for shares of Alnylam Pharmaceuticals in a report issued on Wednesday, October 2nd. Zacks Research analyst A. Chak…
Earnings · Nasdaq 100 · Pharmaceuticals · Science